RAB9AP2

Q-omics provides the consensus-scored RAB9AP2 profile across patient tissues and cancer cell-line models. RAB9AP2 expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in UCEC. Additionally, RAB9AP2 RNA expression shows 1,020 significant gene co-expression associations, with the highest sampling consensus in STAD. Together, these results highlight UCEC, and STAD as cancer lineages where RAB9AP2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes RAB9AP2 survival associations across molecular data types. RAB9AP2 RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RAB9AP2 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	UCEC (108)	view →

This table ranks reproducible RAB9AP2 RNA expression–survival associations across cancer types. High RAB9AP2 expression shows unfavorable associations in UCEC and OV. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCEC as the clearest survival context for RAB9AP2 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.198	0.873	<.001	108	view →
OV	DFS	Tertile	All	0.101	0.541	<.001	54	view →

Pink = unfavorable, green = favorable. all 2 lineages →

RAB9AP2-UCEC (OS)

Explore this curve interactively →